Vegard Skogen - Infectious Diseases

Author Information

Vegard Skogen is associated with the Department of Infectious Diseases, Division of Internal Medicine at the University Hospital of North Norway in Tromsø, Norway. His research appears to focus on infectious diseases, with particular emphasis on conditions such as HIV and COVID-19. His work contributes significantly to understanding and managing these diseases in clinical settings.

Research Contributions

Vegard Skogen has authored numerous papers spanning a variety of topics within the field of infectious diseases. Notable studies include examining peer support for individuals living with HIV, identifying new susceptibility loci for severe COVID-19, and exploring the value of open-source clinical science in pandemic response. His research also delves into the symptoms of COVID-19, the prevalence and predictors of fatigue among people living with HIV, and the empirical prescribing of antibiotics for pneumonia. Additionally, he has explored the use of Tenofovir as a treatment for multiple sclerosis and assessed the impact of age on the outcomes of candidemia. His work is critical in advancing the understanding of these diseases and improving patient care.

Aliases

Vegard Skogen has published under several aliases, including "V Skogen," "V. Skogen," and "Vegard Skogen."

Publication and Citation Metrics

Metric	Value
Citation Count	1446
H-index	16
Paper Count	49

Publications:

Peer support in an outpatient clinic for people living with human immunodeficiency virus: a qualitative study of service users’ experiences

DOI: 10.1186/s12913-022-07958-8

Year: 2022

New susceptibility loci for severe COVID-19 by detailed GWAS analysis in European populations

DOI: 10.1101/2021.07.21.21260624

Year: 2021

The value of open-source clinical science in pandemic response: lessons from ISARIC

DOI: 10.1016/S1473-3099(21)00565-X

Year: 2021

COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

DOI: 10.1007/s15010-021-01599-5

Year: 2021

Prevalence and predictors of fatigue among people living with HIV in Norway.

DOI: 10.1080/09540121.2021.1934379

Year: 2021

Empirical prescribing of penicillin G/V reduces risk of readmission of hospitalized patients with community-acquired pneumonia in Norway: a retrospective observational study

DOI: 10.1186/s12890-020-01188-6

Year: 2020

Tenofovir as a treatment option for multiple sclerosis.

DOI: 10.1016/j.msard.2020.102569

Year: 2020

The impact of age on risk assessment, therapeutic practice and outcome in candidemia

DOI: 10.1080/23744235.2019.1595709

Year: 2019

This is the final draft post-refereeing of Predictors of HIV risk behaviors among a national sample of Russian men who have sex with men Published in AIDS and Behavior Authors:

DOI:

Year: 2018

Springboard to an academic career—A national medical student research program

DOI: 10.1371/journal.pone.0195527

Year: 2018

When Are Antivirals Prescribed?

What About Parasitic Pathogens?

How is Pink Eye Diagnosed?

What Are Common Infectious Diseases Screened During Check-Ups?

Why is a Malaria Vaccine Important?

Are There Any Concerns About Drug Resistance?

Can the Inflammatory Response be Modulated?

What is a Retrovirus?

How is Efficacy Measured?

What Pathogens Can Be Detected in Stool Samples?

Partnered Content Networks

Relevant Topics